Login
$ATRC
$55.31 -$1.53 (2.69%) Live

$ATRC SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
10 Nov 2026 Form 4: Johnson B Kristine, Director

Sold 2,452 shares ($143K)

06 Nov 2026 144
05 Nov 2026 Form 4: Privitera Salvatore, Chief Technical Officer

Sold 8,404 shares ($546K)

04 Nov 2026 144
04 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition

MASON, Ohio, November 3, 2026 – AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today anno...

30 Oct 2026 SCHEDULE 13G/A
05 Oct 2026 SCHEDULE 13G/A
24 Sep 2026 Form 4: Privitera Salvatore, Chief Technical Officer

Sold 4,519 shares ($271K)

23 Sep 2026 144
14 Sep 2026 Form 4: Groves Regina E, Director

Sold 5,313 shares ($288K)

11 Sep 2026 144
10 Sep 2026 Form 4: Privitera Salvatore, Chief Technical Officer

Sold 3,657 shares ($201K)

08 Sep 2026 144
04 Sep 2026 Form 4: Privitera Salvatore, Chief Technical Officer

Sold 7,763 shares ($408K)

02 Sep 2026 144
26 Aug 2026 Form 4: Dahlquist Karl S., Chief Legal Officer

Sold 9,370 shares ($458K)

24 Aug 2026 144
14 Aug 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support